Arcellx (ACLX) Non-Current Assets (2021 - 2025)

Arcellx (ACLX) recorded quarterly Non-Current Assets of $141.8 million in Q4 2025, down 22.86% quarter-over-quarter from $183.8 million in Q3 2025, and up 26.59% on a YoY basis from $112.0 million in Q4 2024.

Arcellx (ACLX) Non-Current Assets (2021 - 2025) Analysis & Trends

Arcellx's Non-Current Assets history runs 5 years deep, the most recent figure standing at $141.8 million for Q4 2025.

  • In Q4 2025, Non-Current Assets rose 26.59% year-over-year to $141.8 million; the TTM figure through Dec 2025 stood at $574.8 million (down 16.06% YoY), while the FY2025 annual figure was $141.8 million, up 26.59% from the prior year.
  • Non-Current Assets was $141.8 million for Q4 2025 at Arcellx, down from $183.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $204.1 million in Q2 2024 to a low of $16.0 million in Q4 2021.
  • Historically, Non-Current Assets has averaged $105.3 million across 5 years, with a median of $108.8 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Assets soared 270.25% in 2024, then tumbled 50.81% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $16.0 million in 2021, then soared by 193.96% to $47.0 million in 2022, then jumped by 131.65% to $108.8 million in 2023, then rose by 2.99% to $112.0 million in 2024, then advanced by 26.59% to $141.8 million in 2025.
  • The last three Non-Current Assets figures came in at $141.8 million (Q4 2025), $183.8 million (Q3 2025), and $155.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 141.81 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 141.81 Mn
Sep 30, 2025 183.84 Mn
Jun 30, 2025 155.19 Mn
Mar 31, 2025 93.93 Mn
Dec 31, 2024 112.02 Mn
Sep 30, 2024 177.61 Mn
Jun 30, 2024 204.10 Mn
Mar 31, 2024 190.96 Mn
Dec 31, 2023 108.77 Mn
Sep 30, 2023 122.76 Mn
Jun 30, 2023 65.46 Mn
Mar 31, 2023 51.58 Mn
Dec 31, 2022 46.95 Mn
Sep 30, 2022 47.02 Mn
Jun 30, 2022 49.58 Mn
Mar 31, 2022 22.60 Mn
Dec 31, 2021 15.97 Mn